Evidence map›Paper›PMID 32064578›Full record

ArticleJournal of clinical immunology2020

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.

Nicholas Brodszki, Ashley Frazer-Abel, Anete S Grumach, Michael Kirschfink, Jiri Litzman, Elena Perez, Mikko R J Seppänen, Kathleen E Sullivan, Stephen Jolles

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Editorial comment: Efficacy and safety of bacterial immunostimulants in immunodeficient individuals: A systematic review and meta-analysis.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Inborn errors of immunity (primary immunodeficiencies).Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Review
  17. Review
  18. Primary immunodeficiency as a cause of immune-mediated kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 6 countries.

Nicholas BrodszkiDepartment of Pediatrics, Children's Hospital, Skåne University Hospital, Lund, Sweden.
Ashley Frazer-AbelDivision of Rheumatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Anete S GrumachClinical Immunology, Reference Center on Rare Diseases, University Center Health ABC, Santo Andre, SP, Brazil.
Michael KirschfinkInstitute of Immunology, University of Heidelberg, Heidelberg, Germany.
Jiri LitzmanDepartment of Clinical Immunology and Allergology, St Anne's University Hospital, and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Elena PerezAllergy Associates of the Palm Beaches, North Palm Beach, FL, USA.
Mikko R J SeppänenRare Disease Center, Children's Hospital, and Adult Primary Immunodeficiency Outpatient Clinic, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kathleen E SullivanDivision of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Stephen JollesImmunodeficiency Centre for Wales, Cardiff University & University Hospital of Wales, Cardiff, UK. jollessr@cardiff.ac.uk.ORCID 0000-0002-7394-6804
Allergy Associates of the Palm Beaches · USChildren's Hospital of Philadelphia · USHeidelberg University · DEMasaryk University · CZSkåne University Hospital · SEUniversity Hospital of Wales · GBUniversity of Colorado Denver · USUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for ~5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.

Indexed as

Autoimmune DiseasesComplement System ProteinsDisease SusceptibilityEuropeGenetic TestingHumansInfectionsInflammationMutationPatient Education as TopicPractice Guidelines as TopicPrimary Immunodeficiency DiseasesSocieties, MedicalComplement System Proteinsalternative pathwayclassical pathwayComplementcomplement deficienciesmannan-binding lectin

Identifiers

PMID32064578
PMCPMC7253377
OpenAlexW3007016379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.